Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva and Targretin in Advanced NSCLC
NCT00411632Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2006
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in non-small cell lung cancer (NSCLC), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2006; status: completed.
02
Drugs
bexarotene
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00411632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411632.